Total hip arthroplasty in patients who have sickle-cell hemoglobinopathy.
Eleven patients who had a form of sickle-cell hemoglobinopathy had a total hip arthroplasty for avascular necrosis of the hip. Four patients had a revision and three had a resection arthroplasty. Four had a serious infection postoperatively. Both acute and late complications were numerous. We concluded that patients who have a sickle-cell hemoglobinopathy are at markedly increased risk for complications after total hip replacement arthroplasty, yet that over-all the results are favorable.
Bishop
A R
AR
Emory University School of Medicine, Atlanta, Georgia 30322.
Roberson
J R
JR
Eckman
J R
JR
Fleming
L L
LL
D000293:Adolescent; D000328:Adult; D000755:Anemia, Sickle Cell / Q000150:complications*; D005260:Female; D005271:Femur Head Necrosis / Q000209:etiology / Q000601:surgery*; D006622:Hip Prosthesis; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D019736:Prostheses and Implants; D012086:Reoperation; D012189:Retrospective Studies; D013530:Surgical Wound Infection / Q000601:surgery